TriSalus Life Sciences, Inc.
TLSIMedical Devices
$3.86−1.78%As of Oct 29vs prior close
- Market cap
- $237.7M
- P/E (TTM)
- –
- From 52W high
- −48.53%
- EPS (LTM)
- -$1.31
- Revenue (LTM)
- $45.1M
- Net margin
- -62.59%
- Dividend yield
- 0.00%
Nomior Score
33
Steady ProfileSpeculativeBottom 18% of the scored universe
Growth69
Quality28
Value29
Momentum39
Resilience38
Growth
+53.85%revenue a year over 3 fiscal years
YE22 $12.4MLTM $45.1M
Connections
Revenue to profitQ2 YE26
The operating loss was 86% of revenue, wider by 21 pts on a year.
Who owns it
2funds